Skip to content

QuidelOrtho Corporation QDEL Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount

Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO

Other financials

Income statement

See full
Revenue$619.8M-10.5%
Gross profit$263.8M-23.2%
Operating income-$31.8M-198%
Net income-$91.8M-623%
EPS (diluted)-$1.35-611%

Balance sheet

See full
Cash & equivalents$140.4M+10.4%
Total debt$3.1B+0.3%
Total equity$1.9B-38.2%
Total assets$5.6B-12.9%

Cash flow

See full
Operating cash flow-$33.0M-150%
CapEx$34.0M-39.5%
Free cash flow-$67.0M-813%

Valuation

See full
Market cap$832.61M-56.1%
Enterprise value$3.8B-22.0%
P/S0.3×-0.4×

Profitability

See full
Gross margin45%-2.0pp
Operating margin-37%-46.2pp
Net margin-45.6%-75.7pp
FCF margin13.8%

Returns & leverage

See full
Return on equity-49.9%-70.8pp
Debt / equity1.7×+0.6×
Current ratio1.4×+0.2×

Where this comes from

Reported directly by QuidelOrtho Corporation in its filing.

Tagged under the XBRL concept us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance.

The official record: QuidelOrtho Corporation’s 10-K, filed February 19, 2026, on SEC EDGAR. View the filing →

Ask your AI about QuidelOrtho Corporation's effective income tax rate reconciliation, change in deferred tax assets valuation allowance, amount.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is QuidelOrtho Corporation's effective income tax rate reconciliation, change in deferred tax assets valuation allowance, amount?
QuidelOrtho Corporation (QDEL) reported effective income tax rate reconciliation, change in deferred tax assets valuation allowance, amount of $19.1M in Q4 2025.
How has QuidelOrtho Corporation's effective income tax rate reconciliation, change in deferred tax assets valuation allowance, amount changed year-over-year?
QuidelOrtho Corporation's effective income tax rate reconciliation, change in deferred tax assets valuation allowance, amount increased by 144.1% year-over-year, from $7.83M to $19.1M.
What is the long-term trend for QuidelOrtho Corporation's effective income tax rate reconciliation, change in deferred tax assets valuation allowance, amount?
Over 2 years (2023 to 2025), QuidelOrtho Corporation's effective income tax rate reconciliation, change in deferred tax assets valuation allowance, amount has grown at a 171.0% compound annual growth rate (CAGR), from $10.4M to $76.4M.
What does effective income tax rate reconciliation, change in deferred tax assets valuation allowance, amount mean?
Represents the absolute dollar impact on the income tax provision resulting from adjustments to the valuation allowance for deferred tax assets. This metric reflects management's assessment of the likelihood that deferred tax assets will be realized in future periods based on projected taxable income.